person · Reporting owner

EISENBERG GLENN A

Disclosed activity across 10 companies

Tapewire entity: 18882
SEC CIK: 0001222831

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Fortrea Holdings Inc.FTRE · Entity 4623	Director · Executive Vice President	June 20, 2023	June 21, 2023
LABCORP HOLDINGS INC.LH · Entity 1277	Executive Vice President	March 27, 2025	March 31, 2025
Lumexa Imaging Holdings, Inc.LMRI · Entity 4888	Director	June 10, 2026	June 12, 2026
MIDDLEBY CorpMIDD · Entity 3889	Director	July 20, 2026	August 28, 2026
MiniMed Group, Inc.MMED · Entity 3758	Director	October 09, 2026	October 13, 2026
SEQUENOM INCSQNM · Entity 182543	Director · EVP and Treasurer	September 07, 2016	September 07, 2016
Solventum CorpSOLV · Entity 1645	Director	May 15, 2026	May 18, 2026
US Ecology, Inc.ECOL · Entity 127674	Director	May 02, 2022	May 03, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Fortrea Holdings Inc.

Report date June 20, 2023 · Filed June 21, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	42,176	Reported balance After 2023-06-20 transaction · row 1 1 source row Row 1 · 2023-06-20 · Other · Acquired 42,176 · Balance 42,176 F1: In connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), Labcorp will distribute all of the outstanding shares of Fortrea common stock held by Labcorp to Labcorp common stockholders as of the record date, which was the close of business on June 20, 2023 (the "Record Date"). For each share of Labcorp common stock held on the Record Date, Labcorp will distribute one share of Fortrea common stock.

Filing footnotes · ownership attribution and instrument terms

F1: In connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), Labcorp will distribute all of the outstanding shares of Fortrea common stock held by Labcorp to Labcorp common stockholders as of the record date, which was the close of business on June 20, 2023 (the "Record Date"). For each share of Labcorp common stock held on the Record Date, Labcorp will distribute one share of Fortrea common stock.

LABCORP HOLDINGS INC.

Report date March 27, 2025 · Filed March 31, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	37,920	Ending reported balance After 2025-03-27 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2025-03-27 · Grant · Acquired 8,305 · Balance 41,550 F1: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024. Row 2 · 2025-03-27 · Tax withholding · Disposed 3,630 · Balance 37,920 F2: Stock withholding to satisfy tax withholding obligations.

Filing footnotes · ownership attribution and instrument terms

F1: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024.

F2: Stock withholding to satisfy tax withholding obligations.

Lumexa Imaging Holdings, Inc.

Report date June 10, 2026 · Filed June 12, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	19,358	Reported balance After 2026-06-10 transaction · row 1 1 source row Row 1 · 2026-06-10 · Grant · Acquired 19,358 · Balance 19,358 F1: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer.

MIDDLEBY Corp

Report date July 20, 2026 · Filed August 28, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	1,510	Reported balance After 2026-07-20 transaction · row 1 1 source row Row 1 · 2026-07-20 · Conversion · Acquired 349 · Balance 1,510 F1: Represents the conversion of 1,161 RSUs into 1,510 RSUs pursuant to the adjustment required by the Employee Matters Agreement entered into in connection with the spin-off of Midera Food Processing, Inc. from Middleby, which was completed on July 6, 2026.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the conversion of 1,161 RSUs into 1,510 RSUs pursuant to the adjustment required by the Employee Matters Agreement entered into in connection with the spin-off of Midera Food Processing, Inc. from Middleby, which was completed on July 6, 2026.

MiniMed Group, Inc.

Report date October 09, 2026 · Filed October 13, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	25,684	Reported balance After 2026-10-09 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-10-09 · Grant · Acquired 11,795 · Balance 25,684 F1: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date. F2: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date.

F2: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.

SEQUENOM INC

Report date September 07, 2016 · Filed September 07, 2016

This filing explicitly reported no securities owned.

Solventum Corp

Report date May 15, 2026 · Filed May 18, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	3,300	Reported balance After 2026-05-15 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-05-15 · Grant · Acquired 3,300 · Balance 3,300 F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2: The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

F2: The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date.

US Ecology, Inc.

Report date May 02, 2022 · Filed May 03, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2022-05-02 transaction · row 1 1 source row Row 1 · 2022-05-02 · Disposition to issuer · Disposed 9,000 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. ("Parent") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest ("Merger Consideration").

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on February 8, 2022, by and among the Issuer, Republic Services, Inc. ("Parent") and Bronco Acquisition Corp. (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on February 10, 2022). At the effective time of the merger, each Issuer share of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $48.00 per share in cash without interest ("Merger Consideration").

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Perspecta Inc.

Report date May 06, 2021 · Filed May 06, 2021

Section 16 reporting ended · disclosed 2021-05-06. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2021-05-06 transaction · row 1 1 source row Row 1 · 2021-05-06 · Disposition to issuer · Disposed 14,400 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among Perspecta Inc. (the "Company"), Jaguar ParentCo Inc. ("Parent") and Jaguar Merger Sub Inc. ("Merger Sub"), on May 6, 2021, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.01 per share, of the Company (each, a "Share") was canceled and converted into the right to receive $29.35 in cash without interest and less any applicable tax withholdings.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among Perspecta Inc. (the "Company"), Jaguar ParentCo Inc. ("Parent") and Jaguar Merger Sub Inc. ("Merger Sub"), on May 6, 2021, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.01 per share, of the Company (each, a "Share") was canceled and converted into the right to receive $29.35 in cash without interest and less any applicable tax withholdings.

US Ecology Holdings, Inc.

Report date November 01, 2019 · Filed November 01, 2019

Section 16 reporting ended · disclosed 2019-11-01. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2019-11-01 transaction · row 1 1 source row Row 1 · 2019-11-01 · Disposition to issuer · Disposed 3,000 · Balance 0 F1: Disposed pursuant to that certain Agreement and Plan of Merger, dated as of June 23, 2019, by and among US Ecology Holdings, Inc. (f/k/a US Ecology, Inc.) ("Parent"), NRC Group Holdings Corp., US Ecology, Inc. (f/k/a US Ecology Parent, Inc.) ("Holdco"), ECOL Merger Sub, Inc. ("ECOL Merger Sub") and Rooster Merger Sub, Inc., in a merger transaction in which ECOL Merger Sub merged with and into Parent, and each issued and outstanding share of Parent's common stock was converted into the right to receive, and became exchangeable for, one share of common stock, par value $0.01 of Holdco.

Filing footnotes · ownership attribution and instrument terms

F1: Disposed pursuant to that certain Agreement and Plan of Merger, dated as of June 23, 2019, by and among US Ecology Holdings, Inc. (f/k/a US Ecology, Inc.) ("Parent"), NRC Group Holdings Corp., US Ecology, Inc. (f/k/a US Ecology Parent, Inc.) ("Holdco"), ECOL Merger Sub, Inc. ("ECOL Merger Sub") and Rooster Merger Sub, Inc., in a merger transaction in which ECOL Merger Sub merged with and into Parent, and each issued and outstanding share of Parent's common stock was converted into the right to receive, and became exchangeable for, one share of common stock, par value $0.01 of Holdco.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 09, 2026 Filed Oct 13, 2026 22:09 UTC	MiniMed Group, Inc. MMED · Entity 3758	GrantCommon Stock	11,795	$0.00	$0.00	Disclosure SEC source: 0001222831-26-000015 · wk-form4_1791929357.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,684 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document
July 20, 2026 Filed Aug 28, 2026 17:03 UTC	MIDDLEBY Corp MIDD · Entity 3889	ConversionCommon Stock	349	Not disclosed	Not disclosed	Disclosure SEC source: 0001222831-26-000013 · wk-form4_1787950980.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents the conversion of 1,161 RSUs into 1,510 RSUs pursuant to the adjustment required by the Employee Matters Agreement entered into in connection with the spin-off of Midera Food Processing, Inc. from Middleby, which was completed on July 6, 2026. Read SEC document
June 10, 2026 Filed Jun 12, 2026 16:22 UTC	Lumexa Imaging Holdings, Inc. LMRI · Entity 4888	GrantCommon Stock	19,358	$0.00	$0.00	Disclosure SEC source: 0000905148-26-002935 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,358 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document
May 15, 2026 Filed May 18, 2026 17:38 UTC	Solventum Corp SOLV · Entity 1645	GrantRestricted Stock Units · Derivative	3,300	$0.00	$0.00	Disclosure SEC source: 0001222831-26-000012 · wk-form4_1779140283.xml · derivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,300 Underlying: Common Stock · 3,300 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date. F2 · derivative.expiration_date: The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date. Read SEC document
April 30, 2026 Filed May 1, 2026 16:28 UTC	Solventum Corp SOLV · Entity 1645	Exercise / conversionRestricted Stock Units · Derivative	3,403	$0.00	$0.00	Disclosure SEC source: 0001222831-26-000010 · wk-form4_1777667290.xml · derivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,403 shares Expires 2035-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs are fully vested. Read SEC document
April 30, 2026 Filed May 1, 2026 16:28 UTC	Solventum Corp SOLV · Entity 1645	Exercise / conversionCommon Stock	3,403	$0.00	$0.00	Disclosure SEC source: 0001222831-26-000010 · wk-form4_1777667290.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 27, 2026 Filed Mar 30, 2026 19:40 UTC	Solventum Corp SOLV · Entity 1645	Exercise / conversionRestricted Stock Units · Derivative	1,980	$0.00	$0.00	Disclosure SEC source: 0001222831-26-000008 · wk-form4_1774914055.xml · derivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,980 shares Expires 2034-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs are fully vested. Read SEC document
March 27, 2026 Filed Mar 30, 2026 19:40 UTC	Solventum Corp SOLV · Entity 1645	Exercise / conversionCommon Stock	1,980	$0.00	$0.00	Disclosure SEC source: 0001222831-26-000008 · wk-form4_1774914055.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 09, 2026 Filed Mar 11, 2026 16:31 UTC	MiniMed Group, Inc. MMED · Entity 3758	GrantCommon Stock	13,889	$0.00	$0.00	Disclosure SEC source: 0001628280-26-016855 · wk-form4_1773261066.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,889 F1 · shares: Represents restricted stock units that vest on the one-year anniversary of the grant date. F2 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document
March 06, 2026 Filed Mar 7, 2026 00:04 UTC	MIDDLEBY Corp MIDD · Entity 3889	GrantCommon Stock	1,161	Not disclosed	Not disclosed	Disclosure SEC source: 0001222831-26-000005 · wk-form4_1772841849.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,161 F1 · price: These shares represent time-based restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock on the applicable vesting date. These restricted stock units will vest in full on March 6, 2027. Vested shares will be issued to the reporting person after the applicable vesting date. Read SEC document
May 13, 2025 Filed May 15, 2025 16:20 UTC	Solventum Corp SOLV · Entity 1645	Exercise / conversionRestricted Stock Units · Derivative	3,564	$0.00	$0.00	Disclosure SEC source: 0001628280-25-025945 · wk-form4_1747340436.xml · derivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,564 shares Expires 2034-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs fully vested on May 13, 2025. Read SEC document
May 13, 2025 Filed May 15, 2025 16:20 UTC	Solventum Corp SOLV · Entity 1645	Exercise / conversionCommon Stock	3,564	$0.00	$0.00	Disclosure SEC source: 0001628280-25-025945 · wk-form4_1747340436.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
April 30, 2025 Filed May 2, 2025 16:28 UTC	Solventum Corp SOLV · Entity 1645	GrantRestricted Stock Units · Derivative	3,403	$0.00	$0.00	Disclosure SEC source: 0001628280-25-021868 · wk-form4_1746217726.xml · derivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,403 Underlying: Common Stock · 3,403 shares Expires 2035-04-30 F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs shall fully vest on April 30, 2026, subject to continued service through the vesting date. Read SEC document
March 27, 2025 Filed Mar 31, 2025 14:26 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	3,630	$231.67	$840,962.10	Disclosure SEC source: 0001127602-25-010618 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,920 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
March 27, 2025 Filed Mar 31, 2025 14:26 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	GrantCommon Stock	8,305	$0.00	$0.00	Disclosure SEC source: 0001127602-25-010618 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,550 F1 · kind: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024. Read SEC document
February 11, 2025 Filed Feb 13, 2025 16:39 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionRestricted Stock Unit · Derivative	807	$0.00	$0.00	Disclosure SEC source: 0001127602-25-004540 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,819 Underlying: Common Stock · 807 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
February 11, 2025 Filed Feb 13, 2025 16:39 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	213	$245.14	$52,214.82	Disclosure SEC source: 0001127602-25-004540 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,245 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
February 11, 2025 Filed Feb 13, 2025 16:39 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	807	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-25-004540 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,458 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document
February 07, 2025 Filed Feb 10, 2025 15:14 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionRestricted Stock Unit · Derivative	885	$0.00	$0.00	Disclosure SEC source: 0001127602-25-003723 · form4.xml · derivative · entry 6 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,626 Underlying: Common Stock · 885 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
February 07, 2025 Filed Feb 10, 2025 15:14 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	234	$246.27	$57,627.18	Disclosure SEC source: 0001127602-25-003723 · form4.xml · nonDerivative · entry 4 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,651 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
February 07, 2025 Filed Feb 10, 2025 15:14 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	885	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-25-003723 · form4.xml · nonDerivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document
February 06, 2025 Filed Feb 10, 2025 15:14 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionRestricted Stock Unit · Derivative	966	$0.00	$0.00	Disclosure SEC source: 0001127602-25-003723 · form4.xml · derivative · entry 5 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,511 Underlying: Common Stock · 966 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
February 06, 2025 Filed Feb 10, 2025 15:14 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	255	$247.74	$63,173.70	Disclosure SEC source: 0001127602-25-003723 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
February 06, 2025 Filed Feb 10, 2025 15:14 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	966	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-25-003723 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock. Read SEC document
December 02, 2024 Filed Dec 4, 2024 14:59 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionNon-qualified Stock Options · Derivative	2,788	$0.00 Strike: $221.67	$0.00	Disclosure SEC source: 0001127602-24-028580 · form4.xml · derivative · entry 5 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,577 Underlying: Common Stock · 2,788 shares Expires 2033-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. F3 · derivative.exercise_price: Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("LHI"), calculated pursuant to the terms of the Employee Matters Agreement by and between LHI and Fortrea. F3 · shares: Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("LHI"), calculated pursuant to the terms of the Employee Matters Agreement by and between LHI and Fortrea. F5 · derivative.exercise_date: The option vests in three equal annual installments beginning on the date reflected in this column. Read SEC document
December 02, 2024 Filed Dec 4, 2024 14:59 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionNon-qualified Stock Options · Derivative	8,923	$0.00 Strike: $209.25	$0.00	Disclosure SEC source: 0001127602-24-028580 · form4.xml · derivative · entry 4 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,923 shares Expires 2031-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. F3 · derivative.exercise_price: Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("LHI"), calculated pursuant to the terms of the Employee Matters Agreement by and between LHI and Fortrea. F3 · shares: Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("LHI"), calculated pursuant to the terms of the Employee Matters Agreement by and between LHI and Fortrea. F4 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column. Read SEC document
December 02, 2024 Filed Dec 4, 2024 14:59 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	11,711	$240.43	$2,815,651.14	Disclosure SEC source: 0001127602-24-028580 · form4.xml · nonDerivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,289 F1 · price: The price of $240.4279 per share represents a weighted average of sales prices ranging from $240.015 to $240.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
December 02, 2024 Filed Dec 4, 2024 14:59 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	2,788	$221.67	$618,015.96	Disclosure SEC source: 0001127602-24-028580 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 02, 2024 Filed Dec 4, 2024 14:59 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	8,923	$209.25	$1,867,137.75	Disclosure SEC source: 0001127602-24-028580 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 15, 2024 Filed Aug 19, 2024 14:22 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	9,071	$224.55	$2,036,882.16	Disclosure SEC source: 0001127602-24-022401 · form4.xml · nonDerivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,289 F3 · price: The price of $224.5488 per share represents a weighted average of sales prices ranging from $224.25 to $224.91 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
August 15, 2024 Filed Aug 19, 2024 14:22 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	2,950	$223.62	$659,669.86	Disclosure SEC source: 0001127602-24-022401 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,360 F2 · price: The price of $223.6169 per share represents a weighted average of sales prices ranging from $223.25 to $224.162 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
August 15, 2024 Filed Aug 19, 2024 14:22 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	2,979	$222.65	$663,272.56	Disclosure SEC source: 0001127602-24-022401 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,310 F1 · price: The price of $222.6494 per share represents a weighted average of sales prices ranging from $222.25 to $223.15 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
May 13, 2024 Filed May 15, 2024 16:45 UTC	Solventum Corp SOLV · Entity 1645	GrantRestricted Stock Units · Derivative	1,980	$0.00	$0.00	Disclosure SEC source: 0001127602-24-015486 · form4.xml · derivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,544 Underlying: Common Stock · 1,980 shares Expires 2034-05-13 F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs shall fully vest on March 27, 2026, subject to continued service through the vesting date. Read SEC document
May 13, 2024 Filed May 15, 2024 16:45 UTC	Solventum Corp SOLV · Entity 1645	GrantRestricted Stock Units · Derivative	3,564	$0.00	$0.00	Disclosure SEC source: 0001127602-24-015486 · form4.xml · derivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,564 Underlying: Common Stock · 3,564 shares Expires 2034-05-13 F1 · derivative.exercise_price: Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. F2 · derivative.exercise_date: The RSUs shall fully vest on May 13, 2025, subject to continued service through the vesting date. Read SEC document
April 30, 2024 Filed May 2, 2024 16:45 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionPerformance Share Unit · Derivative	10,229	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-24-013820 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,229 shares Expires 2024-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Performance Share represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock. F3 · shares: Amount includes an additional 1,059 Performance Shares resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea Holdings Inc. ("Fortrea"). F1 · price: Each Performance Share represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock. F4 · derivative.exercise_date: The Performance Shares vested in full upon the filing of the Company's Quarterly Report on Form 10-Q for the first quarter of 2024, subject to both continued service and satisfaction of a performance condition related to the spin-off of Fortrea. F3 · derivative.underlying_shares: Amount includes an additional 1,059 Performance Shares resulting from the final adjustment ratio calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea Holdings Inc. ("Fortrea"). Read SEC document
April 30, 2024 Filed May 2, 2024 16:45 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	4,496	$201.37	$905,359.52	Disclosure SEC source: 0001127602-24-013820 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,289 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
April 30, 2024 Filed May 2, 2024 16:45 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	10,229	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-24-013820 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Performance Share represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock. Read SEC document
April 15, 2024 Filed Apr 17, 2024 12:25 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionRestricted Stock Unit · Derivative	10,229	$0.00	$0.00	Disclosure SEC source: 0001127602-24-013046 · form4.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,477 Underlying: Common Stock · 10,229 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in full on April 15, 2024. F3 · derivative.expiration_date: The Restricted Stock Units vested in full on April 15, 2024. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document
April 15, 2024 Filed Apr 17, 2024 12:25 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	4,496	$203.32	$914,126.72	Disclosure SEC source: 0001127602-24-013046 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,556 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
April 15, 2024 Filed Apr 17, 2024 12:25 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	10,229	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-24-013046 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document
March 27, 2024 Filed Mar 29, 2024 20:50 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionRestricted Stock Unit · Derivative	20,033	Not disclosed	Not disclosed	Disclosure SEC source: 0000920148-24-000018 · primary_doc.xml · derivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,706 Underlying: Common Stock · 20,033 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock. F1 · price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock. F3 · derivative.exercise_date: As previously reported, in connection with the spin-off ("Spin-Off") of Fortrea Holdings Inc. ("Fortrea") by Labcorp, performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the "2021 PSA") were converted into time-vesting RSUs of Labcorp pursuant to the terms of the Employee Matters Agreement (the "EMA") by and between Labcorp and Fortrea. The 2021 PSA was converted into a number of time-vesting Labcorp RSUs, based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the final adjustment ratio applied to Labcorp equity awards in connection with the Spin-Off, calculated pursuant to the terms of the EMA, which fully vested on March 27, 2024. F3 · derivative.expiration_date: As previously reported, in connection with the spin-off ("Spin-Off") of Fortrea Holdings Inc. ("Fortrea") by Labcorp, performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the "2021 PSA") were converted into time-vesting RSUs of Labcorp pursuant to the terms of the Employee Matters Agreement (the "EMA") by and between Labcorp and Fortrea. The 2021 PSA was converted into a number of time-vesting Labcorp RSUs, based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the final adjustment ratio applied to Labcorp equity awards in connection with the Spin-Off, calculated pursuant to the terms of the EMA, which fully vested on March 27, 2024. F4 · balance_after: This number reflects the aggregate number of RSUs held by the reporting person. Read SEC document
March 27, 2024 Filed Mar 29, 2024 20:50 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	8,805	$216.57	$1,906,898.85	Disclosure SEC source: 0000920148-24-000018 · primary_doc.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,823 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document
March 27, 2024 Filed Mar 29, 2024 20:50 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	20,033	Not disclosed	Not disclosed	Disclosure SEC source: 0000920148-24-000018 · primary_doc.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock. Read SEC document
February 21, 2024 Filed Feb 22, 2024 20:05 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionNon-qualified Stock Options · Derivative	14,054	$0.00 Strike: $163.63	$0.00	Disclosure SEC source: 0001127602-24-006253 · form4.xml · derivative · entry 6 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,054 shares Expires 2030-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F6 · derivative.exercise_price: Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea. F6 · shares: Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea. F7 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column. Read SEC document
February 21, 2024 Filed Feb 22, 2024 20:05 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	1,553	$217.98	$338,529.46	Disclosure SEC source: 0001127602-24-006253 · form4.xml · nonDerivative · entry 5 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,595 F4 · price: The price of $217.9842 per share represents a weighted average of sales prices ranging from $217.89 to $218.075 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
February 21, 2024 Filed Feb 22, 2024 20:05 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	6,665	$217.52	$1,449,774.13	Disclosure SEC source: 0001127602-24-006253 · form4.xml · nonDerivative · entry 4 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,148 F3 · price: The price of $217.5205 per share represents a weighted average of sales prices ranging from $216.87 to $217.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
February 21, 2024 Filed Feb 22, 2024 20:05 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	7,907	$215.68	$1,705,349.34	Disclosure SEC source: 0001127602-24-006253 · form4.xml · nonDerivative · entry 3 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,813 F2 · price: The price of $215.6759 per share represents a weighted average of sales prices ranging from $215.80 to $216.66 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
February 21, 2024 Filed Feb 22, 2024 20:05 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	SaleCommon Stock	18,379	$215.37	$3,958,213.55	Disclosure SEC source: 0001127602-24-006253 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,720 F1 · price: The price of $215.3661 per share represents a weighted average of sales prices ranging from $214.80 to $215.79 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document
February 21, 2024 Filed Feb 22, 2024 20:05 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Exercise / conversionCommon Stock	14,054	$163.63	$2,299,656.02	Disclosure SEC source: 0001127602-24-006253 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 12, 2024 Filed Feb 13, 2024 17:16 UTC	LABCORP HOLDINGS INC. LH · Entity 1277	Tax withholdingCommon Stock	215	$227.45	$48,901.75	Disclosure SEC source: 0001127602-24-004642 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,045 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.